Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
123 hedge funds and large institutions have $490M invested in Radius Health, Inc. in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 31 closing their positions.
6% more capital invested
Capital invested by funds: $464M → $490M (+$25.9M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less call options, than puts
Call options by funds: $8.14M | Put options by funds: $8.83M
11% less funds holding
Funds holding: 138 → 123 (-15)
33% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 49
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$8.79M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.04M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$3.55M |
| 4 |
D.E. Shaw & Co
New York
|
+$3.37M |
| 5 |
NM
Newtyn Management
New York
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.84M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.98M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.02M |
RDUS Hedge Fund Activity: Q2 2022 in Review
123 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q2 2022, worth a combined $490M — up 5.6% from $464M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of RDUS and 19 opened new positions — a net loss of 12 holders — while 49 trimmed existing stakes and 33 added.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $8.79M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $14.4M sold.
- 123 institutional investors held Radius Health, Inc. (RDUS) as of Q2 2022, down from 138 in Q1 2022.
- Funds reported $490M of Radius Health, Inc. stock for Q2 2022, up 5.6% quarter-over-quarter.
- 19 funds opened new Radius Health, Inc. positions in Q2 2022 and 31 closed out, a net change of -12 holders.
- The largest Radius Health, Inc. buyer in Q2 2022 was Alpine Associates Management, an estimated $8.79M added.
- The largest Radius Health, Inc. seller in Q2 2022 was T. Rowe Price Associates, an estimated $14.4M sold.
Based on aggregated 13F filings for Q2 2022.